FHCCX vs. FBTCX
Compare and contrast key facts about Fidelity Advisor Health Care Fund Class C (FHCCX) and Fidelity Advisor Biotechnology Fund Class C (FBTCX).
FHCCX is managed by Fidelity. It was launched on Nov 3, 1997. FBTCX is managed by Fidelity. It was launched on Dec 27, 2000.
Performance
FHCCX vs. FBTCX - Performance Comparison
Loading graphics...
FHCCX vs. FBTCX - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
FHCCX Fidelity Advisor Health Care Fund Class C | -9.80% | -5.49% | 3.20% | 3.02% | -13.72% | 10.43% | 20.15% | 26.96% | 6.37% | 23.12% |
FBTCX Fidelity Advisor Biotechnology Fund Class C | -2.86% | 38.48% | -2.00% | 9.86% | -8.64% | -3.72% | 31.17% | 24.82% | -4.55% | 24.81% |
Returns By Period
In the year-to-date period, FHCCX achieves a -9.80% return, which is significantly lower than FBTCX's -2.86% return. Over the past 10 years, FHCCX has underperformed FBTCX with an annualized return of 5.57%, while FBTCX has yielded a comparatively higher 9.77% annualized return.
FHCCX
- 1D
- -0.72%
- 1M
- -9.58%
- YTD
- -9.80%
- 6M
- -16.82%
- 1Y
- -13.69%
- 3Y*
- -3.33%
- 5Y*
- -3.13%
- 10Y*
- 5.57%
FBTCX
- 1D
- -0.75%
- 1M
- -6.13%
- YTD
- -2.86%
- 6M
- 10.98%
- 1Y
- 41.66%
- 3Y*
- 15.08%
- 5Y*
- 5.77%
- 10Y*
- 9.77%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
FHCCX vs. FBTCX - Expense Ratio Comparison
FHCCX has a 1.72% expense ratio, which is lower than FBTCX's 1.75% expense ratio.
Return for Risk
FHCCX vs. FBTCX — Risk / Return Rank
FHCCX
FBTCX
FHCCX vs. FBTCX - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Fidelity Advisor Health Care Fund Class C (FHCCX) and Fidelity Advisor Biotechnology Fund Class C (FBTCX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| FHCCX | FBTCX | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | -0.56 | 1.52 | -2.08 |
Sortino ratioReturn per unit of downside risk | -0.55 | 2.06 | -2.61 |
Omega ratioGain probability vs. loss probability | 0.90 | 1.26 | -0.36 |
Calmar ratioReturn relative to maximum drawdown | -0.55 | 2.31 | -2.86 |
Martin ratioReturn relative to average drawdown | -1.35 | 9.25 | -10.59 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading graphics...
Sharpe Ratios by Period
| FHCCX | FBTCX | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | -0.56 | 1.52 | -2.08 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | -0.16 | 0.25 | -0.41 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.29 | 0.40 | -0.11 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.45 | 0.26 | +0.19 |
Correlation
The correlation between FHCCX and FBTCX is 0.83, which is considered to be high. That indicates a strong positive relationship between their price movements. Having highly-correlated positions in a portfolio may signal a lack of diversification, potentially leading to increased risk during market downturns.
Dividends
FHCCX vs. FBTCX - Dividend Comparison
FHCCX has not paid dividends to shareholders, while FBTCX's dividend yield for the trailing twelve months is around 1.73%.
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
FHCCX Fidelity Advisor Health Care Fund Class C | 0.00% | 0.00% | 17.59% | 0.00% | 0.00% | 8.32% | 6.85% | 0.41% | 6.43% | 0.00% | 0.00% | 7.84% |
FBTCX Fidelity Advisor Biotechnology Fund Class C | 1.73% | 1.68% | 0.00% | 0.00% | 0.00% | 24.50% | 9.78% | 7.92% | 2.92% | 0.00% | 0.00% | 5.73% |
Drawdowns
FHCCX vs. FBTCX - Drawdown Comparison
The maximum FHCCX drawdown since its inception was -45.28%, smaller than the maximum FBTCX drawdown of -64.04%. Use the drawdown chart below to compare losses from any high point for FHCCX and FBTCX.
Loading graphics...
Drawdown Indicators
| FHCCX | FBTCX | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -45.28% | -64.04% | +18.76% |
Max Drawdown (1Y)Largest decline over 1 year | -27.25% | -13.63% | -13.62% |
Max Drawdown (5Y)Largest decline over 5 years | -29.67% | -37.26% | +7.59% |
Max Drawdown (10Y)Largest decline over 10 years | -29.67% | -39.37% | +9.70% |
Current DrawdownCurrent decline from peak | -27.25% | -7.46% | -19.79% |
Average DrawdownAverage peak-to-trough decline | -10.12% | -23.21% | +13.09% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 11.08% | 4.16% | +6.92% |
Volatility
FHCCX vs. FBTCX - Volatility Comparison
The current volatility for Fidelity Advisor Health Care Fund Class C (FHCCX) is 5.59%, while Fidelity Advisor Biotechnology Fund Class C (FBTCX) has a volatility of 7.76%. This indicates that FHCCX experiences smaller price fluctuations and is considered to be less risky than FBTCX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading graphics...
Volatility by Period
| FHCCX | FBTCX | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 5.59% | 7.76% | -2.17% |
Volatility (6M)Calculated over the trailing 6-month period | 22.17% | 16.37% | +5.80% |
Volatility (1Y)Calculated over the trailing 1-year period | 25.40% | 25.57% | -0.17% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 19.34% | 23.40% | -4.06% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 19.55% | 24.62% | -5.07% |